Comparison Tool

Select a country from the regions above then, add your country to our comparison tool to compare country specific information simultaneously across 3 countries

Argentina


Fast Facts

  • Capital: Buenos Aires
  • Economy: upper middle-income economy,and Latin America's third-largest. Nominal GDP US$447.6 billion, 2011
  • Health Expenditure: 97.7%
  • Population: 44 million in 2017
  • Average Life Span: 76 Years, 2011
  • Languages: Spanish (official)
  • Adult Literacy Rate: 97.7%

Health trends

  • Health expenditure = 6.21% GDP (2009)
  • 64% of population have health insurance either through work unions (46.4%)
    or private health insurance plans (15.6%). 37% do not have health insurance
    and rely on the public health system, mostly decentralised at provincial level
  • 153,000 hospital beds (4.5 beds / 1,000 pop)
  • 121,000 physicians
  • Mortality patterns and trends similar to developed nations (2009):
    • Infant mortality: 12.1 / 1,000 lb
    • Malignant Neoplasms = 143.2 / 100,000 pop.
    • Ischemic Heart Diseases = 46.8 / 100,000 pop.
    • Cerebrovascular Diseases = 48.2 / 100,000 pop.
    • Diabetes Mellitus = 20.2 / 100,000 pop.
  • Hypertension prevalence = 33.5% male, 35.9% female (2005-2009)
  • Diabetes Mellitus 2 prevalence = 8.9% male, 10.2% female (2005-2009)
  • Tuberculosis Incidence = 19.2 / 100,000 pop. (2009)
  • HIV/AIDS Incidence = 3.2 / 100,000 pop.
  • HIV/AIDS Prevalence = 0.5% adult pop.
  • Organs Transplant (2011):
    • 15.1 donors per million pop.
    • 1377 transplants: 913 Renal, 332 Liver, 106 Heart, 75 Pancreatic, 26 Lung

Clinical Trial Landscape

  • Argentine pharmaceutical market has reported sales of $4,300+ USD (2010). It is expected to be the18th largest world market by 2015 (IMS Market Prognosis, April 2011)
  • Argentina represents ~ 16% of the LATAM clinical research market in terms of approved studies (# 3)
  • ANMAT (National Administration for Drugs, Food and Medical Technology / MOH) regulates and approves clinical trials at national level. Provincial regulations are also applicable.
    • ~1000 clinical trials approved (2007-2011)
    • 154 clinical trials approved: Oncology (29%), Diabetes (15%) Cardiovascular (13%), Infectious Diseases (11%), CNS (11%), Respiratory (11%), Rheumatology (11%) (2011)
    • Average ANMAT approval timelines = 20 - 24 weeks (2011)
    • Electronic submission process launched in Q3 2012 will reduce review timelines 
       

ICON in Argentina

Add to Comparison Tool
  • ICON established its Latin American operations in Buenos Aires in 1998 
  • 93 employees, 2017
  • 169 projects awarded (1999-YTD 2012)
  • Top 5 therapeutic areas by awarded projects: Oncology (38), CNS (28), Cardiovascular (19), Infectious Diseases (19), Diabetes (18)

Services Offered

  • Clinical Operations:
    • Clinical Trial Management, Feasibilities, Study Start Up, Monitoring
    • Investigators Contract Negotiation & Payment Administration
    • Clinical Trial Materials Logistics (Importation, Depot & Distribution vendors management)
  • Medical & Safety Services
  • Quality Assurance
  • DOCS Resourcing Solutions 
    • Functional Resourcing 
    • Flexible Resourcing
    • Permanent Recruitment

Contact Us for further information